Investors high on Oncimmune distribution deal
AIM-listed cancer immunodiagnostics firm Oncimmune Holdings has announced a US distribution agreement for two of its blood test products
6 years ago
Latest
Time to invest in China?
China Special Situations has suffered as a result of the trade war tensions but could be a good one for…
6 years ago
Velocys shares take off on jet fuel project
The price of shares in AIM-listed Velocys have risen by 13.01% to 4.57p after it acquired a site for a UK…
6 years ago
GlaxoSmithKline up on joint venture news
The prices of shares in GlaxoSmithKline has risen by 7.62% after the company announced that it would form a consumer healthcare…
6 years ago
Investors raise 888 after update
Online gambling operator 888 Holdings has confirmed that EBITDA for the year ending 31st December will be in line with expectations.
6 years ago
Mellon on the Markets: Thoughts for 2019
Inside the mind of the Master Investor: UK billionaire investor Jim Mellon reveals his trading and investing strategy for 2019.
6 years ago
FCA broadens Telit Communications probe
Telit Communications has seen its share price drop after the Financial Conduct Authority widened its investigation into the company's activities.
6 years ago
Redt Energy delays push shares into negative territory
AIM-listed power storage firm Redt Energy announced that the financial close of the first part of its German portfolio would be…
6 years ago
Petrofac shares rise on trading assurances
Petrofac said that trading in the year ending 31st December was in line with expectations, with more than $5 billion…
6 years ago
Evil Knievil: Reality sinks in for ASOS
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
6 years ago